Pegtibatinase
培替巴泰酶
Report date: 2026/05/09 20:00:18
Base Information
Drug NamePegtibatinase
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[13]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTravere Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesTravere Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A